• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Corticosteroids decrease treatment failure in severe community-acquired pneumonia

byReshmi MadankumarandPriyanka Vedak
February 17, 2015
in Infectious Disease, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Use of acute corticosteroids versus placebo in patients with severe community-acquired pneumonia (CAP) and a high initial inflammatory response resulted in a decrease in treatment failure.

2. There was no statistically significant difference in in-hospital mortality between the two groups.

Evidence Rating Level: 1 (Excellent)

Study Rundown: The mortality of patients with community-acquired pneumonia (CAP) is high, with severe CAP and treatment failure being two factors associated with increased mortality. A high host inflammatory response is linked to treatment failure in patients with CAP. While corticosteroids may have a potential beneficial role in this disease process, given their ability to modulate cytokines and anti-inflammatory properties, their role in CAP has not been well elucidated.

This study aimed to examine the effect of corticosteroids on treatment failure in patients with severe CAP and a high initial inflammatory response. The primary outcome was rate of treatment failure. Patients were randomized to either a placebo group or an intervention of methylprednisolone. It was found that acute administration of methylprednisolone did in fact decrease treatment failure in this population of patients affected by CAP. A major strength of this study is that it targeted a subset of patients most likely to benefit from steroids – those with severe disease and with a high inflammatory state. This study is, however, limited by its applicability to a subset of patients affected by CAP, long duration and sub-optimal statistical power. Nevertheless, the findings support methylprednisolone use as a potential adjunctive treatment for CAP.

Click to read the study, published today in JAMA

RELATED REPORTS

The 2 Minute Medicine Podcast Episode 54

The Scan by 2 Minute Medicine®: Measles Outbreak, Tariffs and Healthcare, Pope’s Pneumonia, and Removing Fluoride from Water:

Biomarkers may help guide antibiotic stewardship in community acquired pneumonia

Click to read an accompanying editorial in JAMA

Relevant Reading: Corticosteroids in the Treatment of Community-Acquire Pneumonia in Adults: A Meta-Analysis

In-Depth [randomized controlled trial]: This study was a randomized, placebo-controlled trial. Patients with severe CAP and a high initial inflammatory response (i.e., C-reactive protein >150 mg/L) were randomized to placebo (n=59) or to receive an IV bolus of 0.5 mg/kg of methylprednisolone every 12 hours for 5 days within 36 hours of admission (n=61). The primary outcome was rate of treatment failure. The methylprednisolone group had less treatment failure compared to the placebo group (13% vs. 31%, respectively; p=0.02). It was found that there was a significant reduction in late treatment failure due to a decrease in radiographic progression when comparing the two groups (p=0.04). However, the benefit of steroids remained in post-hoc analyses excluding radiographic progression. There were no significant differences in in-hospital mortality, clinical stability, and length of ICU and hospital stays when comparing the two groups.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: corticosteroidpneumonia
Previous Post

Tight blood pressure control associated with increased mortality in the elderly [PARTAGE Trial]

Next Post

Endovascular stroke treatment reduces mortality

RelatedReports

The 2 Minute Medicine Podcast Episode 15
2MM Podcast

The 2 Minute Medicine Podcast Episode 54

March 21, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Measles Outbreak, Tariffs and Healthcare, Pope’s Pneumonia, and Removing Fluoride from Water:

March 18, 2025
Prescription of antibiotics for acute respiratory infections increasing
Emergency

Biomarkers may help guide antibiotic stewardship in community acquired pneumonia

August 26, 2024
Lisinopril and carvedilol reduce cardiotoxicity in breast cancer patients receiving trastuzumab and anthracyclines
Cardiology

Use of fluoroquinolones and may increase the risk of aortic and mitral regurgitation

July 30, 2024
Next Post
Endovascular stroke treatment reduces mortality

Endovascular stroke treatment reduces mortality

FDA-regulated clinical trials rarely report violations

Eliglustat decreases spleen size in Type I Gaucher disease [ENGAGE Trial]

Smokeless tobacco use in children has not changed

Varenicline therapy increases smoking cessation rates

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Large language models show potential to provide feedback on research papers on a large-scale
  • #VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer
  • Fecal microbiota transplantation may be more effective than vancomycin in treating primary C. difficile infection
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.